ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3568-75, 2012. ,
DOI : 10.1128/AAC.06330-11
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa, Scientific Reports, vol.13, issue.1, p.26717, 2016. ,
DOI : 10.1093/bioinformatics/btl446
URL : http://www.nature.com/articles/srep26717.pdf
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy, Antimicrobial Agents and Chemotherapy, vol.49, issue.7, pp.2874-2882, 2005. ,
DOI : 10.1128/AAC.49.7.2874-2878.2005
URL : http://aac.asm.org/content/49/7/2874.full.pdf
Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects, Virology, vol.443, issue.2, pp.187-96, 2013. ,
DOI : 10.1016/j.virol.2013.05.022
Clinical Aspects of Phage Therapy, Adv Virus Res, vol.83, pp.73-121, 2012. ,
DOI : 10.1016/B978-0-12-394438-2.00003-7
T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production, PLoS ONE, vol.222, issue.1, p.71036, 2013. ,
DOI : 10.1371/journal.pone.0071036.t004
URL : https://doi.org/10.1371/journal.pone.0071036
Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface, Journal of Virology, vol.88, issue.21, pp.12551-12558, 2014. ,
DOI : 10.1128/JVI.02043-14
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency, Blood, vol.80, pp.1163-71, 1992. ,
Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy, Front Microbiol, vol.7, p.1681, 2016. ,
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing, Cell Systems, vol.1, issue.3, pp.187-96, 2015. ,
DOI : 10.1016/j.cels.2015.08.013
URL : https://doi.org/10.1016/j.cels.2015.08.013
Phage Therapy in the Era of Synthetic Biology, Cold Spring Harbor Perspectives in Biology, vol.8, issue.10, 2016. ,
DOI : 10.1101/cshperspect.a023879
; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-57, 2009. ,
DOI : 10.3201/eid0809.020063
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, EBioMedicine, vol.4, pp.124-161, 2016. ,
DOI : 10.1016/j.ebiom.2015.12.023
Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, pp.543-74, 2014. ,
DOI : 10.1128/CMR.00125-13
URL : https://hal.archives-ouvertes.fr/hal-01061609
clonal complex, Journal of Antimicrobial Chemotherapy, vol.2, issue.11, pp.3072-80, 2016. ,
DOI : 10.1093/jac/dks261
URL : https://hal.archives-ouvertes.fr/pasteur-01539016
Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition, Environmental Microbiology, vol.350, issue.7, pp.2237-2282, 2016. ,
DOI : 10.1126/science.aad6791
URL : https://hal.archives-ouvertes.fr/pasteur-01538960
pathogenicity, World Journal of Gastrointestinal Pathophysiology, vol.5, issue.3, pp.213-240, 2014. ,
DOI : 10.4291/wjgp.v5.i3.213
Morbidité et mortalité des infections à bactéries multi-résistantes aux antibiotiques en France en 2012, Étude Burden BMR. Saint-Maurice : Institut de Veille Sanitaire (InVS), 2015. ,
Antibiotic resistance threats in the United States, Atlanta : CDC, 2013. ,
The gut is the epicentre of antibiotic resistance, Antimicrobial Resistance and Infection Control, vol.1, issue.1, p.39, 2012. ,
DOI : 10.1093/cid/cir025
URL : https://aricjournal.biomedcentral.com/track/pdf/10.1186/2047-2994-1-39?site=aricjournal.biomedcentral.com
Rapport du groupe de travail spécial pour la préservation des antibiotiques. Paris : Ministère des Affaires sociales, 2015. ,
Revisiting phage therapy: new applications for old resources, Trends in Microbiology, vol.23, issue.4, pp.185-91, 2015. ,
DOI : 10.1016/j.tim.2015.01.006
Phage-Host Interaction: an Ecological Perspective, Journal of Bacteriology, vol.186, issue.12, pp.3677-86, 2004. ,
DOI : 10.1128/JB.186.12.3677-3686.2004
URL : http://jb.asm.org/content/186/12/3677.full.pdf
Global Phage Diversity, Cell, vol.113, issue.2, p.141, 2003. ,
DOI : 10.1016/S0092-8674(03)00276-9
URL : https://doi.org/10.1016/s0092-8674(03)00276-9
The bacteriophages in human- and animal body-associated microbial communities, Journal of Applied Microbiology, vol.4, issue.1, pp.1-13, 2009. ,
DOI : 10.1016/S1383-5718(00)00003-6
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2672.2009.04143.x/pdf
The significance of viruses to mortality in aquatic microbial communities, Microbial Ecology, vol.31, issue.2, pp.237-280, 1994. ,
DOI : 10.1007/BF00166813
Bacteria???phage coevolution as a driver of ecological and evolutionary processes in microbial communities, FEMS Microbiology Reviews, vol.80, issue.5, pp.916-947, 2014. ,
DOI : 10.1016/j.mib.2013.08.008
URL : https://academic.oup.com/femsre/article-pdf/38/5/916/18143202/38-5-916.pdf
Sur un microbe invisible antagoniste des bacilles dysentériques, CR Acad Sci Paris, vol.165, pp.373-75, 1917. ,
Phage treatment of human infections, Bacteriophage, vol.7, issue.2, pp.66-85, 2011. ,
DOI : 10.1016/S0041-1345(03)00525-6
URL : http://europepmc.org/articles/pmc3278644?pdf=render
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications, Applied Microbiology and Biotechnology, vol.28, issue.Pt 2, pp.2141-51, 2016. ,
DOI : 10.1007/s40259-013-0081-y
Phage therapy of pulmonary infections, Bacteriophage, vol.129, issue.1, p.1020260, 2015. ,
DOI : 10.2217/FMB.15.28
URL : http://europepmc.org/articles/pmc4422798?pdf=render
Bacteriophages in the Experimental Treatment of Pseudomonas aeruginosa Infections in Mice, Adv Virus Res, vol.83, pp.123-164, 2012. ,
DOI : 10.1016/B978-0-12-394438-2.00004-9
Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages*, Critical Care Medicine, vol.43, issue.6, pp.190-198, 2015. ,
DOI : 10.1097/CCM.0000000000000968
URL : https://hal.archives-ouvertes.fr/pasteur-01539037
Lung Infections, The Journal of Infectious Diseases, vol.201, issue.7, pp.1096-104, 2010. ,
DOI : 10.1086/651135
URL : https://hal.archives-ouvertes.fr/pasteur-01425464
Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro, Frontiers in Microbiology, vol.4, issue.437, p.1029, 2016. ,
DOI : 10.1371/journal.pone.0004944
URL : https://hal.archives-ouvertes.fr/pasteur-01539081
Safety and efficacy of phage therapy via the intravenous route, FEMS Microbiology Letters, vol.51, issue.3, 2016. ,
DOI : 10.1097/00007890-198202000-00008
URL : https://academic.oup.com/femsle/article-pdf/363/3/fnv242/10754110/fnv242.pdf
Phage-Antibiotic Synergy (PAS): ??-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth, PLoS ONE, vol.50, issue.8, p.799, 2007. ,
DOI : 10.1371/journal.pone.0000799.g005
URL : https://hal.archives-ouvertes.fr/hal-00180524
Revenge of the phages: defeating bacterial defences, Nature Reviews Microbiology, vol.71, issue.10, pp.675-87, 2013. ,
DOI : 10.1016/0042-6822(76)90382-2
Remarkable Mechanisms in Microbes to Resist Phage Infections, Annual Review of Virology, vol.1, issue.1, pp.307-338, 2014. ,
DOI : 10.1146/annurev-virology-031413-085500
The phage-host arms race: Shaping the evolution of microbes, BioEssays, vol.34, issue.1, pp.43-51, 2011. ,
DOI : 10.1093/oxfordjournals.molbev.a004046
URL : http://europepmc.org/articles/pmc3274958?pdf=render
A Fresh Appraisal of Bacteriophage Therapy, The Journal of Infectious Diseases, vol.201, issue.1, pp.52-61, 2010. ,
DOI : 10.1086/648478
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.4, pp.1358-65, 2011. ,
DOI : 10.1128/AAC.01123-10
Debarbieux Tarifs d'abonnement m/s, p.2017 ,
, Abonnez-vous à médecine/sciences > Grâce à m/s, vivez en direct les progrès des sciences biologiques et médicales Bulletin d'abonnement page 450 dans ce